Pulmonx Corp income statement

In fiscal 2025, Pulmonx Corp reported revenue of $90.5m, up 8.0% on the year before, operating income of −$53.7m (a -59.3% margin) and net income of −$54.0m, or −$1.33 per diluted share. Every line below comes from the company's 10-K and 10-Q filings; column headings link to the filing.

Income statement

US$ millions unless shown otherwise. Fiscal years, plus the last twelve months (LTM) when newer.

Pulmonx Corp: income statement, annual
Fiscal year	2018Dec 2018	2019Dec 2019	2020Dec 2020	2021Dec 2021	2022Dec 2022	2023Dec 2023	2024Dec 2024	2025Dec 2025	LTMJun 2026
Revenue	20	33	33	48	54	69	84	90	87
Cost of revenue	8	10	12	13	14	18	22	23	20
Gross profit	12	22	21	36	40	51	62	67	67
Research and development	7	6	7	13	15	18	18	19	19
Selling, general and administrative	20	34	46	70	83	95	102	101	94
Operating income	−15	−18	−32	−47	−59	−62	−58	−54	−46
Interest expense	3	2	3	1	1	3	4	3	4
Income before tax	−18	−20	−32	−48	−59	−60	−56	−53	−48
Income tax	0	0	0	0	0	1	1	1	1
Net income	−18	−21	−32	−49	−59	−61	−56	−54	−48
Diluted EPS	−$11.03	−$11.66	−$3.16	−$1.35	−$1.59	−$1.60	−$1.44	−$1.33	−$1.15
Diluted shares (average)	2m	2m	10m	36m	37m	38m	39m	41m	42m
EBITDA	−15	−18	−32	−47	−57	−61	−57	−53	−45

US$ millions unless shown otherwise. Fiscal quarters.

Pulmonx Corp: income statement, quarterly
Quarter	2024 Q3Sept 2024	2024 Q4Dec 2024	2025 Q1Mar 2025	2025 Q2Jun 2025	2025 Q3Sept 2025	2025 Q4Dec 2025	2026 Q1Mar 2026	2026 Q2Jun 2026
Revenue	20	24	23	24	22	23	21	23
Cost of revenue	5	6	6	7	5	5	5	5
Gross profit	15	18	16	17	16	18	16	18
Research and development	4	4	5	5	5	5	5	5
Selling, general and administrative	25	27	26	27	26	23	24	22
Operating income	−14	−13	−15	−15	−14	−10	−13	−9
Interest expense	1	1	1	1	1	1	1	1
Income before tax	−14	−13	−14	−15	−14	−10	−14	−10
Income tax	0	0	0	0	0	0	0	0
Net income	−14	−13	−14	−15	−14	−10	−14	−10
Diluted EPS	−$0.36	−$0.33	−$0.36	−$0.38	−$0.34	−$0.25	−$0.33	−$0.24
EBITDA	−14	−13	−14	−15	−14	−10	−13	−9

EBITDA is operating income plus depreciation and amortisation. EPS and share counts are restated for stock splits. A dash means the company did not report the line for that period; expense lines are shown as reported, so they need not add up to the totals when a company reports other items between them.

Compare with peers

Head to head: IRMD vs LUNG LUNG vs SGHT DCTH vs LUNG

More: Health Care Equipment stocks compared, Health Care sector, rankings of US companies

Figures from Pulmonx Corp's SEC filings (10-K and 10-Q), retrieved October 29, 2026. How we read and check them: methodology and data sources. Not investment advice. Back to Pulmonx Corp.